Melissa Eamer’s mother had been the sort of person who made a home into a workshop: art projects, forts, tadpoles. Later, the activity ebbed. The bridge games, volunteering and travel receded. Eamer wanted to understand why. Years afterward, that question became Modern Age, a company selling something more intimate than a blood test: the possibility of feeling less helpless about getting older.
- One clinic connected aging assessments, hormone care, weight management and cosmetic treatments.
- The original business raised $33 million, then closed in March 2024 after a funding shortfall.
- The Upper East Side location reopened under new ownership that August.
- Today’s assessment page lists $1,500; older $500 descriptions belong to an earlier offer.
A birthday is a poor medical history
Eamer had spent nearly two decades at Amazon and served as Glossier’s chief operating officer. She knew how to make a complicated purchase feel approachable. Aging presented a rather larger problem than finding the right moisturizer. A person’s concerns might involve fatigue, memory, hair loss and menopause, each sending them toward a different specialist.
Modern Age grouped those concerns around one question: how are you aging? Its original audience was primarily women aged 35 to 45, though the company now describes its customers more broadly as adults in their thirties and beyond. The organizing idea was a life stage rather than a single organ. That made room for both medical concerns and the perfectly ordinary wish to like one’s reflection.
An hour to connect the dots
The original Aging Wellness Assessment combined bloodwork, a bone scan and digital cognitive and subjective-age tests. The last measured how old someone felt. That was an interesting consumer insight, provided it stayed in its lane: the company’s terms describe its subjective-age tool as educational rather than a substitute for medical advice.
The appointment after testing was the important part. Modern Age advertised an hour with a clinician to interpret results and discuss recommendations. A laboratory can deliver numbers. A patient still needs to know which numbers matter, which questions to ask and what happens next. The clinic sold that conversation alongside the measurements.
- 01MeasureBloodwork and assessment
- 02InterpretOne-hour clinician review
- 03PlanTreatments and lifestyle steps
- 04RevisitOptional ongoing care
The current assessment page advertises more than 100 blood biomarkers, hormone and metabolic evaluation, and personalized recommendations. Its broader menu includes hormone therapy, clinician-supervised weight management, IV drips, injections, skin treatments and hair restoration. Botox and blood panels make unusual companions, but they address anxieties that often arrive together.
This was a service business with a consumer storefront. Customers could book consultations, purchase assessments, return for treatments and buy products. Digital access extended the relationship beyond the clinic. The company’s FAQ advertises virtual consultations in several states, while physical services center on New York.
The price of paying attention
In 2023, public accounts described a $500 assessment. The current assessment product page lists $1,500. Those prices should not be casually merged: the advertised test panel has changed too. The present Optimization Program landing page separately lists $1,500 for an annual plan, with follow-up care, diagnostic testing, medication management and discounts.
Some FAQ text still describes older prices and durations. A prospective customer should settle those details before buying. The distinction between an assessment and ongoing care matters: learning what a clinician recommends does not automatically purchase the entire course of treatment.
Modern Age’s FAQ says it does not accept insurance. That places the company in the market for people able and willing to pay directly for attention, coordination and convenience. Compared with a lab-focused service such as Function Health, its proposition extends into physical treatments. Compared with booking separate specialists, the attraction is having more of the conversation in one place.
$33 million meets the next round
The financing initially looked persuasive. Juxtapose led a $6 million seed round; a $27 million Series A followed in October 2021, led by Oak HC/FT with GV and Juxtapose participating. The first clinic opened in 2022. The ambition was to turn a personal concern into a repeatable health-care experience.
On March 22, 2024, the original business announced its closure. Eamer said it had been unable to raise the capital needed to continue operating. The documented failure was access to further funding. Calling it a failure of patient demand, a particular treatment or a specific clinic expense would go beyond the evidence.
The consequence was immediate: a care relationship needed another destination. Modern Age referred patients elsewhere and arranged medical-record access. Preventive medicine asks people to think years ahead. A clinic also has to get through the next month.
A second life, with a referral route
By August 2024, the Upper East Side clinic had reopened. Ali Rashan, founder of ClearMD, purchased Modern Age’s intellectual property and became its CEO. The Flatiron location did not reopen at that time. Modern Age remained separate, with a closer connection to ClearMD for referrals beyond its own menu.
That change addressed a practical boundary: what happens when a preventive assessment points toward care the clinic does not provide? ClearMD already offered primary care and gynecology; Rashan saw a place for a preventive arm. The November relaunch announcement named Nandini Yadav medical director.
“Our mission is to help clients feel their best, inside and out.”
Ali Rashan · November 2024 relaunch
What survives the business model
The useful thing to copy is the sequence: measure, explain, agree on a plan, return to it. Modern Age’s published culture likewise starts with customers and makes room for disagreement and changing course. Those are sensible habits for a service whose clients bring uncertainty through the door.
The conditions matter. A self-pay clinic is a poor fit for someone needing insured care at minimal cost. An assessment is less useful without interpretation and follow-through. And a longevity label should not turn every test or cosmetic procedure into a promise of extra years. Modern Age’s second life leaves the reader with a concrete question: who will help you make sense of the results, and keep helping afterward?